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Furin is one of seven proprotein convertase family members that promote proteolytic maturation of proproteins 1 . It is induced in activated T cells and is reported to process a variety of substrates including the anti-inflammatory cytokine transforming growth factor (TGF)-b1 (refs 2-4), but the non-redundant functions of furin versus other proprotein convertases in T cells are unclear.
Here we show that conditional deletion of furin in T cells allowed for normal T-cell development but impaired the function of regulatory and effector T cells, which produced less TGF-b1. Furindeficient T regulatory (T reg ) cells were less protective in a T-cell transfer colitis model and failed to induce Foxp3 in normal T cells. Additionally, furin-deficient effector cells were inherently overactive and were resistant to suppressive activity of wild-type T reg cells. Thus, our results indicate that furin is indispensable in maintaining peripheral tolerance, which is due, at least in part, to its non-redundant, essential function in regulating TGF-b1 production. Targeting furin has emerged as a strategy in malignant and infectious disease 5, 6 . Our results suggest that inhibiting furin might activate immune responses, but may result in a breakdown in peripheral tolerance.
Proprotein convertases are important for the maturation of multiple cellular substrates, but the identification of non-redundant, bona fide enzyme/substrate pairs is lacking. Furthermore, germline deletion of furin is embryonically lethal, limiting our understanding of the physiological function of this proprotein convertase 7 . To investigate furin's role in T cells, we crossed mice homozygous for floxed fur alleles 8 with mice expressing Cre recombinase under the control of the CD4 promoter (designated CD4cre-fur f/f mice). T-cellspecific deletion of fur resulted in a viable mouse in which furin messenger RNA and protein were virtually absent in both CD4 and CD8 compartments ( Supplementary Fig. 1 ). Furin-deficient T cells underwent normal thymic development as evidenced by normal absolute T-cell numbers (data not shown), ratios of thymic subsets and T-cell antigen receptor (TCR)-b rearrangement (Fig. 1a) . In young animals, the absolute numbers of T cells, proportions of CD4 1 and CD8 1 T cells and TCR Vb subsets in peripheral lymphoid organs (spleen and lymph nodes) were also not significantly different from the fur f/f littermate controls (data not shown and Supplementary Fig. 2 ). In addition, partial deletion of the Vb5 1 subset in peripheral CD4
1 but not CD8 1 T cells was evident in the absence of furin, suggesting that negative selection of thymocytes is intact ( Supplementary Fig. 2 ) 9 . Thus, deletion of furin at the doublepositive stage of T-cell development did not appear to have major developmental consequences. Intriguingly though, the numbers of thymic, natural T regulatory (T reg , CD4 1
Foxp3
1 ) cells were found to be significantly elevated in CD4cre-fur f/f animals ( Fig. 1b) . Although deleting furin in double-positive thymocytes did not grossly affect T-cell development, furin deficiency in T cells was associated with increased numbers of activated, memory-like CD4
1

CD44
hi CD62L 2 and CD8 1 CD44 hi CD122 1 T cells in the periphery even in 7-to 9-week-old mice (Fig. 1c) . To gain more insight into the biological consequence of the absence of furin in T cells, we performed microarray analysis on sorted naive, CD4
CD4cre-fur f/f and littermate fur f/f T cells (greater than 98% purity). Although the cells were isolated based on their naive phenotype, the absence of furin was associated with the upregulation of several genes typically associated with T-cell activation, including Fos, Jun and Ifng ( Supplementary Fig. 3 ). Moreover, upon activation, furin-deficient T cells were observed to produce greater amounts of Th1-(interferon (IFN)-c) and Th2 (interleukin (IL)-4 and IL-13)-type cytokines, less IL-2 and equivalent levels of TNF or IL-17 ( Fig. 1d and Supplementary  Fig. 4) .
At approximately 6 months of age, CD4cre-fur f/f , but not littermate fur f/f or CD4cre-fur
, mice became overtly ill, at which point they developed a progressive wasting disease characterized by weight loss, ruffled hair and hunched appearance. Gross pathological examination of the large intestine and stomach of CD4cre-fur f/f mice revealed macroscopic evidence of inflammation and fibrosis (Fig. 2a) . Mesenteric lymph nodes were enlarged, but obvious splenomegaly was rarely observed. Histologically, mice had severe inflammatory bowel disease characterized by dense chronic inflammation with reactive epithelial atypia and architectural distortion; scattered neutrophils were also observed. Nodules of lymphoid infiltrates were also noted in the liver, lung and kidney, and CD4cre-fur f/f mice were also found to have high levels of anti-nuclear and anti-DNA antibodies, indicative of systemic autoimmune disease (Fig. 2b, c, and Supplementary Figs 4 and 5) . Analysis of serum cytokines in CD4cre-fur f/f mice revealed elevated levels of circulating pro-inflammatory cytokine IL-6, the hallmark Th1 and Th2 cytokines IFN-c and IL-13, respectively, and lower levels of the anti-inflammatory cytokine IL-10 (Fig. 2d ). In addition, there was secondary activation of B cells, as evidenced by elevated levels of the serum immunoglobulins IgG1, IgG2 and IgE (Fig. 2e ). In the gut and mesenteric lymph nodes of older, autoimmune CD4cre-fur f/f animals, we also observed expansion of CD4 1 and CD8 1 effector cells, as well as upregulation of the activation marker CD69 on CD4 1 effector cells (Fig. 3a, b) . Together with the evidence of T-cell activation, autoantibody production and hyperproduction of Th1 and Th2 cytokines, these data suggest that CD4cre-fur f/f mice had a breakdown in immune tolerance. Regulatory T cells are critical components of T-cell-dependent peripheral tolerance 10 . We found that mice in which furin was deleted in T cells had elevated numbers and proportions of peripheral CD4 1
Foxp3
1 cells in the small intestine and mesenteric lymph nodes (Fig. 3a, d) . Production of the anti-inflammatory cytokine TGF-b1 by T reg and effector T cells is also critical in the maintenance of peripheral tolerance and prevention of autoimmune disease [11] [12] [13] . TGF-b1 is initially synthesized as a proprotein that requires multiple steps to generate the mature, biologically active cytokine 14 . The proprotein is enzymatically cleaved to generate an amino-terminal latency associated peptide, but this product remains non-covalently associated with TGF-b1, keeping it in a biologically inactive state. Previous studies with recombinant furin have argued for a role as a pro-TGF-b1 converting enzyme, although other proprotein convertase family members have also been reported to have this activity 2 . We first explored furin's criticality in the production of biologically active TGF-b1 by assessing whether furin-deficient T cells generated normal levels of TGF-b1 in vitro. To this end, we measured the secretion of TGF-b1 by CD4 1
CD25
-and CD4 1 CD25 1 T cells and found that furin-deficient T cells secreted considerably reduced levels of activated TGF-b1 (Fig. 3c) . We confirmed this deficit by measuring TGF-b1 by enzyme-linked immunosorbent assay (ELISA) and western blot using antibodies that selectively detected only active TGF-b1 and not the unprocessed cytokine ( Supplementary Fig. 6c,  d ). In contrast, the levels of surface-expressed latency associated peptide and total Tgfb1 mRNA were not reduced in furin-deficient T cells, consistent with normal production of pro-TGF-b1 ( Supplementary  Fig. 6a, b Supplementary  Fig. 7 , addition of TGF-b1 or wild-type T reg cells induced the expression of Foxp3 in both wild-type and furin-deficient CD4 1 naive T cells. However, furin-deficient T reg cells were defective in their ability to upregulate Foxp3 expression in normal CD4 1 T cells in vitro ( Supplementary Fig. 7 ). This last finding is consistent with the reduced capacity of furin-deficient T cells to produce normal levels of biologically active TGF-b1; however, it is also clear that furindeficient T cells can respond to exogenously added TGF-b1.
To assess whether bioactive TGF-b1 was reduced in the absence of furin in vivo, we first examined the expression of the integrin CD103 on T lymphocytes. This integrin has been linked to T-cell gut homing and retention within epithelial compartments and is known to be induced by 17) . We found that numbers of CD4
Foxp3
2 cells in the lamina propria and intraepithelial compartments were reduced in the small intestines of CD4cre-fur f/f mice compared with wild-type mice (Fig. 3d) .
T-cell-derived TGF-b1 is essential for suppressing autoimmunity, and TGF-b1-deficient T reg cells cannot suppress the inflammatory bowel disease caused by homeostatic expansion of effector T cells 
CD45Rb
hi cells (effectors) were injected into T-cell-deficient hosts alone, or in combination with CD4
1
CD25
1 T reg cells. Mice that received either wild-type or furin-deficient effector cells with no T reg cells lost weight and developed severe gut inflammation macroscopically and histologically ( Fig. 4A-C) . Furin-deficient effector T cells exhibited a more aggressive phenotype, as evidenced by a significant increase in the absolute number of knockout CD4
1 cells in mesenteric lymph nodes (Fig. 4D ). Consistent with previous reports, transfer of wild-type T reg cells with wild-type effectors prevented the wasting disease, gut inflammation, CD4
1 cell expansion and IFN-c production ( Fig. 4 and Supplementary Fig. 8 ) 18 . However, furin-deficient T reg cells were found to be significantly impaired in their ability to prevent gut pathology and weight loss, as well as inhibiting homeostatic proliferation and cytokine production by effector CD4 1 cells. Intriguingly, furin-deficient effectors could not be completely suppressed by wildtype T reg cells (Fig. 4C and Supplementary Fig. 8 ). During homeostatic expansion of naive CD4
1 cells, spontaneous conversion of and age-matched wild-type animals (6 months). b, Haematoxylin-and eosin-stained sections of colon, stomach and liver (6-months-old, CD4cre-fur f/f and fur f/f mice). c, Anti-double-stranded DNA (DA) and nuclear antibody (NA) titres in CD4cre-fur f/f animals compared with age-matched wild-type and fur f/f animals (n 5 8, 5-7 months). 19, 20 . We found that adoptive transfer of naive furin-deficient CD4 1 cells into T-cell-deficient hosts resulted in the generation of fewer Foxp3 1 cells than wild-type cells, perhaps owing to lack of autocrine TGF-b1 production (Fig. 4E) . Lack of spontaneous conversion may contribute to the enhanced aggressiveness of furin-deficient effectors in vivo.
Previous in vitro studies using recombinant proteins have suggested that furin processes a variety of substrates 4 . Fundamental, non-redundant roles in cell biology are suggested by the early lethality of fur germline knockout. However, it was notable that T-cellspecific furin-deficient animals have grossly normal T-cell development, arguing that furin is not required for a plethora of substrates, consistent with the observed partial redundancy of furin in the liver 8 . Rather, selectively deleting furin in T cells, like deleting TGF-b1 in T cells 12 , resulted in autoimmunity and inflammatory bowel disease characterized by elevated numbers of thymic/natural T regulatory cells, hyperproduction of both Th1 and Th2 cytokines and expansion of CD4 1 and CD8 1 cells. Similar to TGF-b1-deficient T cells, in vitro suppressive activity 21 was not impaired (Supplementary Fig. 9 ), but in vivo suppressive activity was reduced, and effector T cells were more aggressive. Thus, CD4cre-fur f/f mice largely phenocopy the abnormalities seen in CD4cre-tgfb f/n mice. The phenotype of CD4cre-fur f/f mice also mimics the pathology seen in mice in which another molecule involved in the activation of TGF-b1, integrin a v b 8 , is deleted in dendritic cells 22 . It is noteworthy, however, that unlike TGF-b1-deficient T reg cells, CD4cre-fur f/f CD4 1 CD25 1 cells are partly functional in vivo and furin-deficient effector cells are more resistant to T reg suppression (Fig. 4) . Undoubtedly, furin has other substrates in T cells, but our results indicate that furin is a critical proprotein convertase in vivo for the proper endoproteolytic processing of TGF-b1. Although other proprotein convertases have also been reported to cleave TGF-b1 in vitro, they evidently cannot replace furin in T cells. Although our data argue for a role of T-cell-expressed furin in the maintenance of peripheral tolerance without obvious effects on thymic selection, more work on furin's role in T-cell development and central tolerance is clearly warranted.
Our results have additional implications. Furin activity has been linked to the pathogenesis of several diseases including metastatic cancers, cystic fibrosis and infectious diseases 4, 5, 23, 24 . Consequently, furin inhibitors have been proposed as possible therapies for such diseases. However, our findings suggest that interfering with furin activity might have the unexpected consequence of promoting autoimmunity. In principle, this might be beneficial in that it might boost T-cell-mediated immune responses and be advantageous in treating cancer and infections.
METHODS SUMMARY
Mice. Mice that expressed floxed fur 8 alleles were backcrossed six times with C57BL/6 mice. Wild-type, CD4-Cre and TCR-a 2/2 mice on C57BL/6 background were from Taconic. Mice were maintained and housed under pathogen-free conditions in accordance with the National Institutes of Health Animal Care and Use Committee. Cell purification and flow cytometry. Cells were purified by magnetic separation (Miltenyi) and sorted with a MoFlo cell sorter (Dako). Flow cytometry was performed with FACSCanto or FACSCalibur instruments (Becton Dickinson) and data were analysed using FlowJo software (Treestar). Cytokine and antibody measurements. Mesenteric lymph node T cells (1 3 10 6 ml
21
) were activated with plate-bound anti-CD3 (10 mg ml 21 ) and soluble anti-CD28 (2 mg ml 21 ; BD Pharmingen). Cytokine levels in supernatants and sera were determined with IL-13 and IL-17 ELISA (R&D Systems) or with Cytometric Bead Array (BD Pharmingen). Serum auto-antibodies and immunoglobulins were determined by ELISA (Alpha Diagnostic International). TGFb1 production by purified CD4 1 CD25 2 and CD4 1 CD25 1 cells was measured after two rounds of activation using a multispecies TGF-b1 ELISA kit (Invitrogen). Gut cell preparation. Intraepithelial lymphocytes were purified from the small intestine using mechanical separation and 30% Percoll centrifugation; lamina propria cells were purified as described 25 . In vivo suppression assay. The T-cell suppression assay was performed as previously described with small modifications 18 . Briefly, TCR-a 2/2 mice were injected intravenously with purified wild-type or furin-deficient naive CD4 Body weight change (%) Med. 204, 1775 Med. 204, -1785 Med. 204, (2007 .
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METHODS
Mice. Mice that expressed floxed fur alleles (fur f/f ) 8 were backcrossed six times with C57BL/6 mice. C57BL/6, CD4-Cre, RAG2
2/2 and TCR-a 2/2 mice, all on C57BL/6 background, were from Taconic. CD4-Cre mice were bred with fur f/f animals to generate T-cell-specific furin knockout (CD4cre-fur f/f ). For in vitro conversion assays, CD4cre-fur f/f animals bearing Foxp3-GFP transgene (from M. Oukka) were used. All mice were housed under pathogen-free conditions in accordance with the National Institutes of Health Animal Care and Use Committee. Flow cytometry. For surface staining, cells were resuspended in fluorescenceactivated cell sorting (FACS) staining buffer (PBS 1 1% FBS) containing 2 mg ml 21 Fc block (BD Pharmingen) and stained on ice for 15-30 min using indicated antibodies from BD Pharmingen or biotinylated anti-latency-associated peptide antibody and goat-IgG from R&D Systems. Intracellular Foxp3 was assessed by intracellular staining according to the manufacturer's instructions, using antibody and buffers from eBiosciences. For intracellular cytokine stainings, cells were activated for 4 h with phorbol myristate acetate and ionomycin; GolgiPlug (BD Pharmingen) was added to cultures after 2 h. Intracellular staining was done with intracellular cytokine staining kit (BD Pharmingen). Cells were analysed using a FACSCalibur or FACSCanto instrument (BD Pharmingen) and data were analysed with Flow-Jo software (Treestar). Cell purification and culture. For quantification of furin deletion efficiency and induced T reg culture, CD4
1 and CD8 1 cells were purified by positive selection using magnetic beads (Miltenyi Biotech). Cells were activated for 3 days with plate-bound anti-CD3 and CD28 antibodies (5 mg ml 21 in PBS), and further expanded for three additional days in complete 10% FBS RPMI supplemented with IL-2 (50 U ml 21 1 Foxp3-GFP 1 and CD4 1 Foxp3-GFP 2 cells were purified by flow cytometry. Western blot and real-time PCR. Western blotting was performed as described 3 using actin (Chemicon), furin (Santa Cruz) or activated TGF-b1 (sc-146, Santa Cruz) antibodies. Total RNA was isolated with RNeasy (Qiagen) and reverse transcribed with complementary DNA synthesis kits (Applied Biosystems). Fur exon two specific real-time polymerase chain reaction was performed using an ABI PRISM 7700 Sequence Detection System as described previously 8 . Cytokine and antibody measurements. Mesenteric lymph node T cells (1 3 10 6 ml 21 ) were activated for 48 h with plate-bound anti-CD3 (10 mg ml
21
) and soluble anti-CD28 (2 mg ml 21 ; BD Pharmingen). Cytokine levels in supernatants or sera were determined with IL-13 and IL-17 ELISA (R&D Systems) or with mouse Th1/Th2 cytokine or inflammation Cytometric Bead Array kits (BD Pharmingen). Serum-circulating anti-DNA and anti-nuclear antibodies, and IgG1, IgG2 and IgE immunoglobulins, were determined with ELISA kits from Alpha Diagnostic International. To determine TGF-b1 production, FACSsorted CD4
1 CD25 2 and CD4 1 CD25 1 were first stimulated for 48 h with anti-CD3 (10 mg ml 21 ) and soluble anti-CD28 (2 mg ml
) in complete RPMI 10% FBS supplemented with IL-2 (50 U ml 21 ), rested 24 h in complete medium, washed twice with PBS and finally re-stimulated in RPMI 1 3% FBS 1 1% Nutridoma (Roche) supplemented with IL-2 (50 U ml
) for another 48 h in the presence or absence of furin inhibitor II (Hexa-d-Arg from Calbiochem). TGF-b1 was measured in the supernatants using a multispecies TGF-b1 ELISA kit (Invitrogen) or ELISA specific for mature/active TGF-b1 (eBiosciences); TGF-b1 concentration in the final stimulation medium was measured and subtracted as background. Microarray analysis. Total RNA from wild-type and furin-deficient CD4 1 CD44 low CD62L 1 cells was extracted with TRIzol reagent (Invitrogen) according to the manufacturer's instructions. Approximately 500 ng of RNA was labelled using a MessageAmp II Biotin Enhanced kit (Ambion) and hybridized to GeneChip Mouse Genome 430 2.0 arrays (Affymetrix) according to the manufacturers' protocols. Gene expression values were determined using GeneChip Operating Software version 1.1.1. Data were analysed using GeneSpring software GX 7.3.1 (Agilent Technologies). Gene expression was normalized across each chip as well as across all experiments. Genes with an average expression value below 50 and those flagged absent in all samples were deleted from subsequent analysis. Isolation of gut intraepithelial and lamina propria lymphocytes. To isolate intraepithelial lymphocytes, Peyer's patches were removed and mouse small intestines were cut into segments of 1-3 cm. Gut pieces were placed in RPMI 2% FBS with constant stirring and incubated for 20 min at 37 uC. After incubation, the gut suspension was strained though a sterile strainer, and flow-through was collected in a beaker on ice. To ensure optimum yield of intraepithelial lymphocytes, gut pieces were placed into a 50-ml tube containing 15 ml of serum-free RPMI, shaken vigorously for 30 s, strained as above and further filtered through a 70-mm cell strainer. Cells were sedimented for 10 min at 1,500 r.p.m. at 4 uC. The cell pellet was re-suspended in 30% Percoll and centrifuged at 1,600 r.p.m. at room temperature for 20 min. The supernatant was discarded and the pellet containing intraepithelial lymphocytes was collected for analysis. Isolation of lamina propria lymphocytes was performed as described previously 25 . In vitro suppression assay. T regulatory cells (three mice per group). Congenic markers CD45.1 and CD45.2 were used to distinguish between transferred cells. Mice were analysed on day seven for effector T-cell proliferation and cytokine production by flow cytometry. In vitro conversion assay. CD4 1 Foxp3 1 T regulatory cells were activated for 4 days with plate-bound anti-CD3 and IL-2 (100 U ml 21 ). The activated T reg cells were then co-cultured for an additional 4 days with CFSE-labelled wild-type or furin-deficient CD4 ) and IL-2 (100 U ml 21 ) as indicated. Cytokine-induced conversion of wild-type or furin-deficient CD4 1 Foxp3 2 effectors was investigated in the absence of T reg cells, but in the presence of dentritic cells and exogenous TGF-b1 (5 ng ml 21 ). CFSE 1 T cells were analysed for Foxp3 expression using flow cytometry. Statistical analysis. P values were calculated using Student's t-test; error bars in graphs represent the s.e.m.
